TO THE EDITOR:
In a recent issue of Journal of Neurogastroenterology and Motility, Park et al 1 examined the roles of stromal interaction molecule 1 (STIM1) and store-operated calcium entryassociated regulatory factor (SARAF) in pacemaker activity of interstitial cells of Cajal (ICCs) from mouse jejunum. Authors employed lipofectamine transfection to deliver STIM1, SARAF, and pcDNA vectors into the cultured ICC and evaluated the changes of pacemaker activities. The results show that the cultured ICCs are capable to produce spontaneously rhythmical pacemaker potentials or slow waves, which traces are very regular and rhythmical, robust and stabilized. For example about a 2-minute control trace the event frequency and amplitude are 14.7 ± 0.8 cycles/minute and -59.6 ± 2.6 mV. Compared with other renowned research groups, the amplitude of slow wave is about 23.0 ± 1.6 mV in whole cell configuration 2 and 20.0 mV using single channel driving force calculation. 3 Based on such much better quality trace, Upon the observation of pacemaker activity expressed in ICC with overexpression of STIM1/SARAF, 1 authors claim that STIM1 "enhances" the pacemaking activity by increasing the frequency of slow waves (ie, 33.6 ± 6.2 cycles/2 minutes in control versus to 48.6 ± 5.2 cycles/2 minutes in STIM1); whereas SARAF "inhibits" the pacemaking by decreasing the frequency (ie, 31.8 ± 3.4 cycles/2 minutes in control versus to 7.6 ± 2.0 cycles/2 minutes in SARAF). It seems that STIM1 facilitates the Ca 2+ influx and SARAF facilitates the Ca 2+ efflux, hence, both effects together are required to compromise to form up the rhythmically electrical pacemaker activity. There are several arguments as follows: first, slow wave is named by its characterization of "slow" in which a relative wider duration or slow upstroke is the must for the intrinsic feature of ICC. Although there is no word of "slow wave" in article, the pacemaker potential should be no difference to "slow wave" here. Looking into the electrical waveforms of STIM1/SARAF, what mostly seen are spike-like events, in which some are mature and mostly are immature. It is seldom to see a regular waveform in traces except for both membrane potentials stay at around -61 mV. Similarly, in Ca 2+ imaging, the event duration is remarkably decreased or the pacemaker activity inhibited due to STIM1/SARAF, compared that of control (empty cDNA transfection). This information suggests the endoplasmic reticulum proteins (STIM1/SARAF) may involve in pacemaker activity in cultured ICC, but it is an impairing effect.
It is curious that along with several baselines from the trace of either electrical or Ca 2+ imaging from ICC treated by STIM1
and SARAF, there are lack of the modulations like CCh, Ca 2+ free and thapsigargin etc which are performed in non-treated ICC as presented in Figure. Of note molecular expressions of STIM1 and SARAF, the observation is screened in normal cultured condition, but not in overexpressional cultures. Without a parallel comparison about transfections on how much "overexpression" of such molecules in treatment versus to control weakens the "role of ER proteins STIM1/ SARAF on pacemaker activity, and this novel study to understand how much is overexpression and the effects whether increase or decrease on ICC pacemaker activity are expected to be followed up. 
